This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

TIA and aspirin

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

Stroke or TIA in patients with non rheumatic atrial fibrilation in whom intracranial haemorrhage has been excluded should be given apirin:

  • in NRAF aspirin prevents 40 vascular events per 1000 patient years of treatment (1).
  • definitive anti-platelet therapy should be commenced at 2 weeks post symptoms

Anticoagulation should be introduced subsequently:

  • in NRAF anticoagulation prevents 90 vascular events per 1000 patient years of treatment (1).

 

Reference:

  • (1) European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet, 1993;342: 1255.

Links:

The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.